Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Improving Sleep and AD Biomarkers

NCT06029894
completednot_applicable

Improving Sleep and Cognition in Alzheimer's Disease

NCT05200208
completednot_applicable

Cognitive Effects of Citicoline on Attention in Healthy Mean and Women

NCT04967157
completednot_applicable

Citicoline Effects on Cortical Membrane Structure and Function

NCT02705066
completednot_applicable

Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment

NCT03369925

Clinical Trials (5)

Showing 5 of 5 trials
NCT06029894Not Applicable

Improving Sleep and AD Biomarkers

Completed
NCT05200208Not Applicable

Improving Sleep and Cognition in Alzheimer's Disease

Completed
NCT04967157Not Applicable

Cognitive Effects of Citicoline on Attention in Healthy Mean and Women

Completed
NCT02705066Not Applicable

Citicoline Effects on Cortical Membrane Structure and Function

Completed
NCT03369925Not Applicable

Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment

Completed

All 5 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
5